SavedAdd your journal

Journals / Anadolu Kardiyoloji Dergisi / 2006 / Cilt: 6 - Sayı: 1

Inflammatory markers in heart failure

Kalp yetersizliğinde inflamatuvar göstergeler

Namık ÖZMEN
Bekir Sıtkı CEBECİ
Ejder KARDEŞOĞLU
Pages
51–54
Publication Date
2022-10-10
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this article, we reviewed inflammatory markers in heart failure and their prognostic significance based on the literature data.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Heart failure is a leading cause of cardiovascular mortality and morbidity.
📊
Key Findings & Data:It has been shown that inflammatory markers may play a role in the pathogenesis of heart failure.
💡
Conclusion & Impact:In this article, we reviewed inflammatory markers in heart failure and their prognostic significance based on the literature data.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Heart failure is a leading cause of cardiovascular mortality and morbidity. It has been shown that inflammatory markers may play a role in the pathogenesis of heart failure. Therefore, inflammatory markers and anticytokine therapy in heart failure have become the attractive subjects in the literature. There are new studies regarding this issue in the literature. In this article, we reviewed inflammatory markers in heart failure and their prognostic significance based on the literature data.

Özet

Kalp yetersizliği, kardiyovasküler mortalite ve morbiditenin başlıca sebeplerinden biridir. İnflamatuvar markırların kalp yetersizliği patogenezinde rol oynayabilecekleri gösterilmiştir. Böylece kalp yetersizliğinde, inflamatuvar göstergeler ve antisitokin tedavi ilgi çekici bir konu haline gelmiştir. Bu konuyla ilgili olarak, literatürde yeni çalışmalar söz konusudur. Bu yazımızda, kalp yetersizliğinde inflamatuvar göstergeler ve prognostik önemlerini literatür bilgileri ışığında derlemeyi uygun bulduk.

🔖

Cite This Article

ÖZMEN, N., CEBECİ, B. S., KARDEŞOĞLU, E. (2022). Inflammatory markers in heart failure. Anadolu Kardiyoloji Dergisi, Cilt: 6 - Sayı: 1, 51–54. https://ajindex.com/articles/437255

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Cohn JN, Archibald DG, Ziesche S, Franciosa JA, Harston WE, Tristani FE, et al. Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study. N Engl J Med. 1986; 314: 1547-52
  2. Packer M, Carver JR, Rodeheffer RJ, Ivanhoe RJ, Di Bianco R, Zeldis SM, et al. Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group. N Engl J Med 1991; 325: 1468-75
  3. Sligl W, McAlister FA, Ezekowitz J, Armstrong PW. Usefulness of spironolactone in a specialized heart failure clinic. Am J Cardiol 2004 Aug 15; 94: 443-7
  4. Func-Brentano C, Lancor R, Hansen S, Hahnloser SH. Predictors of medical events and their competitive interactions in the Cadiac Insufficiency Bisoprolol Study (CIBIS-2). Am Heart J 2001; 6: 989-97
  5. Bozkurt B, Kribbs SB, Clubb FJ Jr, Michael LH, Didenko VV, Hornsby PJ, et al. Pathophysiologically relevant concentrations of tumor necrosis factor-alpha promote progressive left ventricular dysfunction and remodeling in rats. Circulation 1998; 97: 1382-91
  6. The CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure. N Engl J Med 1987; 316: 1429-35
  7. Becker AE, de Boer OJ, van Der Wal AC. The role of inflammation and infection in coronary artery disease. Ann Rev Med 2001; 52: 289-97
  8. Bachmaier K, Neu N, de la Maza LM, Pal S, Hessel A, Penninger JM. Chlamydia infections and heart disease linked through antigenic mimicry. Science 1999; 283: 1335-9
  9. Gauntt CJ, Arizpe HM, Higdon AL, Wood HJ, Bowers DJ, Rozek MM, et al. Molecular mimicry, anti-coxsackievirus B3 neutralizing monoclonal antibodies, and myocarditis. J Immunol 1995; 154: 2983-95
  10. Aukrust P, Ueland T, Lien E, Bendtzen K, Muller F, Andreassen AK, et al. Cytokine network in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 1999; 83: 376-82
  11. Testa M, Yeh M, Lee P, Fanelli R, Loperfido F, Berman JW, et al. Circulating levels of cytokines and their endogenous modulators in patients with mild to severe congestive heart failure due to coronary artery disease or hypertension. J Am Coll Cardiol 1996; 28: 964-71
  12. Torre-Amione G, Kapadia S, Benedict C, Oral H, Young JB, Mann DL. Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: a report from the Studies of Left Ventricular Dysfunction (SOLVD). J Am Coll Cardiol 1996; 27: 1201-6